Beijing Foyou Pharma CO.,LTD

SHSE:601089 Stock Report

Market Cap: CN¥7.3b

Beijing Foyou PharmaLTD Balance Sheet Health

Financial Health criteria checks 6/6

Beijing Foyou PharmaLTD has a total shareholder equity of CN¥3.5B and total debt of CN¥65.2M, which brings its debt-to-equity ratio to 1.9%. Its total assets and total liabilities are CN¥4.5B and CN¥1.1B respectively. Beijing Foyou PharmaLTD's EBIT is CN¥479.8M making its interest coverage ratio -10.6. It has cash and short-term investments of CN¥2.3B.

Key information

1.9%

Debt to equity ratio

CN¥65.23m

Debt

Interest coverage ratio-10.6x
CashCN¥2.30b
EquityCN¥3.47b
Total liabilitiesCN¥1.07b
Total assetsCN¥4.54b

Recent financial health updates

Recent updates

A Look At The Fair Value Of Beijing Foyou Pharma CO.,LTD (SHSE:601089)

Nov 18
A Look At The Fair Value Of Beijing Foyou Pharma CO.,LTD (SHSE:601089)

Does Beijing Foyou PharmaLTD (SHSE:601089) Have A Healthy Balance Sheet?

Sep 29
Does Beijing Foyou PharmaLTD (SHSE:601089) Have A Healthy Balance Sheet?

Investors Shouldn't Be Too Comfortable With Beijing Foyou PharmaLTD's (SHSE:601089) Earnings

Apr 08
Investors Shouldn't Be Too Comfortable With Beijing Foyou PharmaLTD's (SHSE:601089) Earnings

Financial Position Analysis

Short Term Liabilities: 601089's short term assets (CN¥3.1B) exceed its short term liabilities (CN¥1.0B).

Long Term Liabilities: 601089's short term assets (CN¥3.1B) exceed its long term liabilities (CN¥50.4M).


Debt to Equity History and Analysis

Debt Level: 601089 has more cash than its total debt.

Reducing Debt: 601089's debt to equity ratio has reduced from 36.3% to 1.9% over the past 5 years.

Debt Coverage: 601089's debt is well covered by operating cash flow (968.6%).

Interest Coverage: 601089 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies